Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001551163-13-000067
Filing Date
2013-07-15
Accepted
2013-07-15 13:58:57
Documents
13
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 f12dec10kprotect_vedgar2.htm 10-K 858723
2 f12dec10kprotect_vedgar2001.jpg GRAPHIC 17521
3 f12dec10kprotect_vedgar2002.jpg GRAPHIC 88967
4 exhibit311.htm EX-31 11166
5 exhibit312.htm EX-31 11153
6 exhibit321.htm EX-32 2345
7 exhibit322.htm EX-32 2326
  Complete submission text file 0001551163-13-000067.txt   3086303

Data Files

Seq Description Document Type Size
8 prtt-20121231.xml EX-101.INS 201859
9 prtt-20121231.xsd EX-101.SCH 16641
10 prtt-20121231_cal.xml EX-101.CAL 16978
11 prtt-20121231_def.xml EX-101.DEF 22582
12 prtt-20121231_lab.xml EX-101.LAB 86496
13 prtt-20121231_pre.xml EX-101.PRE 74168
Mailing Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109
Business Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109 8013223401
PROTECT PHARMACEUTICAL Corp (Filer) CIK: 0001493526 (see all company filings)

EIN.: 271877179 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54001 | Film No.: 13967803
SIC: 2834 Pharmaceutical Preparations